| |
| |
|
| Insider
Information: |
Milligan John F |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,574,306 |
|
|
Indirect Shares
|
211,755 |
|
|
| Direct
Value |
$100,566,667 |
|
|
|
Indirect Value
|
$7,138,909 |
|
|
| Total
Shares |
1,786,061 |
|
|
| Total
Value |
$107,705,577 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
President and CEO, Dir... |
2018-11-27 |
1,574,306 |
2012-01-06 |
111,755 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-15 |
0 |
2020-12-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
159 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-02-25 |
4 |
OE |
$11.76 |
$235,158 |
D/D |
20,000 |
112,302 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-02-25 |
4 |
S |
$35.28 |
$705,675 |
D/D |
(20,000) |
92,302 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-04-29 |
4 |
OE |
$11.76 |
$352,737 |
D/D |
30,000 |
122,302 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-04-29 |
4 |
S |
$36.22 |
$1,087,751 |
D/D |
(30,000) |
92,302 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-07-22 |
4 |
OE |
$7.41 |
$349,778 |
D/D |
30,000 |
123,021 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-07-22 |
4 |
S |
$43.97 |
$1,319,605 |
D/D |
(30,000) |
93,021 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-11-18 |
4 |
S |
$54.34 |
$1,610,338 |
D/D |
(29,600) |
93,021 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-11-18 |
4 |
OE |
$11.76 |
$352,737 |
D/D |
30,000 |
123,021 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-11-18 |
4 |
S |
$54.53 |
$21,812 |
D/D |
(400) |
119,021 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2006-07-25 |
4 |
OE |
$7.40 |
$521,612 |
D/D |
60,000 |
116,345 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2006-07-25 |
4 |
S |
$60.79 |
$3,648,656 |
D/D |
(60,000) |
98,521 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2006-10-30 |
4 |
S |
$68.61 |
$2,060,442 |
D/D |
(30,000) |
99,241 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2006-10-30 |
4 |
OE |
$7.40 |
$221,955 |
D/D |
30,000 |
129,241 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2006-12-20 |
4 |
OE |
$7.08 |
$28,737 |
D/D |
4,060 |
103,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2007-02-22 |
4 |
OE |
$7.40 |
$186,998 |
D/D |
20,000 |
123,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2007-02-22 |
4 |
S |
$73.59 |
$1,472,251 |
D/D |
(20,000) |
103,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2005-12-23 |
4 |
OE |
$7.08 |
$39,805 |
D/D |
5,500 |
98,521 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2006-02-06 |
4 |
OE |
$11.76 |
$352,737 |
D/D |
30,000 |
128,521 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2006-02-06 |
4 |
S |
$60.50 |
$1,815,881 |
D/D |
(30,000) |
98,521 |
|
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-04-04 |
4 |
OE |
$16.40 |
$1,836,240 |
D/D |
112,000 |
1,170,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-04-04 |
4 |
AS |
$94.54 |
$10,593,904 |
D/D |
(112,000) |
1,058,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-05-02 |
4 |
AS |
$87.27 |
$9,823,954 |
D/D |
(112,000) |
1,058,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-05-02 |
4 |
OE |
$16.40 |
$1,836,240 |
D/D |
112,000 |
1,170,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-06-06 |
4 |
OE |
$16.40 |
$1,836,240 |
D/D |
112,000 |
1,170,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-06-06 |
4 |
AS |
$86.57 |
$9,736,779 |
D/D |
(112,000) |
1,058,963 |
0 |
- |
|
159 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
